Comments from the participants were invited. T. Weinstein gave an overview of the U.S. market. L. Leinan reviewed the issues in other markets. India is also a very important and growing market that should not be overlooked. Japan also has a large aging population which presents good future opportunities.
Japan merely needs to be educated on Canadian capabilities.
The Core Group subsequently agreed that Australia would not be listed as a priority market. Some missions should be directed at the academic-research community China and India are important markets for the pharmaceutical sector because of the fine chemical suppliers located there. Other groups which have activities to list, or would like to make changes in this area, should submit their input to Linda Leinan. CMT activities, which are industry-supported, will be included in the list. There is progress being made on MRA's for Medical Devices and Core members will receive a report.